Cell Bio Human Tech Co.,Ltd (KOSDAQ: 318160)

Cell Bio Human Tech Co.,Ltd Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,504	4,052	4,495	13,929	6,252	10,871
Short-Term Investments	13,487	9,433	2,400	7,463	6,396	14,000
Trading Asset Securities	-	-	-	-	-	5,030
Cash & Short-Term Investments	15,991	13,485	6,895	21,392	12,649	29,901
Cash Growth	37.06%	95.59%	-67.77%	69.12%	-57.70%	272.61%
Accounts Receivable	4,034	4,241	3,072	3,584	4,623	3,875
Other Receivables	50.25	96.49	32.52	154.82	1,001	451.54
Receivables	4,143	4,337	3,104	3,739	5,624	4,327
Inventory	4,636	8,281	9,106	6,254	4,389	2,735
Prepaid Expenses	309.84	308.51	281.85	55.4	14.22	8.09
Other Current Assets	779.69	506.67	548.41	630.85	730.2	165.27
Total Current Assets	25,860	26,918	19,936	32,071	23,406	37,137
Property, Plant & Equipment	22,688	22,764	23,152	23,904	20,983	8,490
Long-Term Investments	1,020	644.17	548.66	509.54	1,932	2,757
Goodwill	-	-	-	-	220.31	-
Other Intangible Assets	1,262	1,282	818.32	817.77	724.56	721.77
Long-Term Deferred Tax Assets	-	557.14	825.57	248.83	27.4	-
Other Long-Term Assets	2,020	1,030	701.66	517.12	602.47	674.57
Total Assets	52,856	53,196	45,982	58,069	47,896	49,780
Accounts Payable	1,209	1,048	861.03	1,953	1,387	650.57
Accrued Expenses	614.9	564.82	709.24	414.39	498.58	442.29
Short-Term Debt	5,146	5,875	4,942	4,735	-	-
Current Portion of Leases	212.51	29.73	220.38	233.33	236.73	402.18
Current Income Taxes Payable	287.49	540.81	573.6	1,449	263.54	144.56
Other Current Liabilities	-15.94	499.72	441.35	833.07	799.12	483.52
Total Current Liabilities	7,455	8,559	7,748	9,617	3,185	2,123
Long-Term Debt	-	-	-	9,421	-	-
Long-Term Leases	211.01	21.89	68.78	274.54	459.18	97.14
Long-Term Deferred Tax Liabilities	-	-	-	-	-	17.51
Other Long-Term Liabilities	44.64	53.07	60.34	29.76	39.36	-
Total Liabilities	7,711	8,634	7,877	19,342	3,684	2,238
Common Stock	4,630	4,630	4,100	4,100	4,100	4,100
Additional Paid-In Capital	23,835	23,835	18,077	18,077	18,070	18,070
Retained Earnings	16,037	13,616	21,086	31,294	28,163	23,976
Treasury Stock	-2,032	-37.25	-7,916	-7,916	-7,916	-
Comprehensive Income & Other	2,228	2,072	-3,648	-17,136	1,227	856.66
Total Common Equity	44,699	44,116	31,700	28,420	43,644	47,002
Minority Interest	-	-	-	-	121.62	93.43
Shareholders' Equity	45,145	44,563	38,105	38,726	44,213	47,542
Total Liabilities & Equity	52,856	53,196	45,982	58,069	47,896	49,780
Total Debt	5,570	5,927	5,232	14,663	695.91	499.32
Net Cash (Debt)	10,421	7,558	1,663	6,728	11,953	29,402
Net Cash Growth	96.80%	354.47%	-75.28%	-43.71%	-59.35%	266.39%
Net Cash Per Share	1207.72	894.55	237.54	852.31	1484.50	3613.15
Filing Date Shares Outstanding	8.78	9.26	7	7	7.16	8.2
Total Common Shares Outstanding	8.78	9.26	7	7	7.16	8.2
Working Capital	18,405	18,359	12,187	22,454	20,221	35,014
Book Value Per Share	5093.09	4765.58	4527.97	4059.42	6096.97	5731.37
Tangible Book Value	43,437	42,834	30,882	27,602	42,700	46,281
Tangible Book Value Per Share	4949.31	4627.08	4411.09	3942.62	5964.98	5643.36
Land	-	2,360	2,360	2,360	2,360	2,329
Buildings	-	8,442	8,459	8,282	422.5	349.3
Machinery	-	10,287	10,742	10,622	5,304	4,329
Construction In Progress	-	128.07	30.27	310.99	11,915	71.5

Source: S&P Capital IQ. Standard template. Financial Sources.